Enlivex Therapeutics share price today

(ENLV)

Enlivex Therapeutics share price is $1.23 & ₹104.79 as on 25 Dec 2024, 2.30 'hrs' IST

$1.23

▲

-0.01

(-0.81%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Enlivex Therapeutics share price in Dollar and Rupees. Guide to invest in Enlivex Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Enlivex Therapeutics. Get details on the Indian mutual funds that are investing in Enlivex Therapeutics. Get Analyst recommendations and forecasts along with all the Enlivex Therapeutics's financials.

Enlivex Therapeutics share price movements

Today's Low: $1.22
Today's High: $1.26
$1.23
0.81%
Downside
Day's Volatility :3.17%
Upside
2.38%
52 Weeks Low: $0.81
52 Weeks High: $4.59
$1.23
34.14%
Downside
52 Weeks Volatility :82.35%
Upside
73.2%

Enlivex Therapeutics Returns

Period	Enlivex Therapeutics Ltd	Index (Russel 2000)
3 Months	-22.15%	0.0%
6 Months	-18.0%	0.0%
1 Year	-56.07%	0.0%
3 Years	-80.48%	-21.1%

Enlivex Therapeutics Key Statistics

in dollars & INR

Previous Close	$1.24
Open	$1.23
Today's High	$1.26
Today's Low	$1.22
Market Capitalization	$27.0M
Today's Volume	$44.8K
52 Week High	$4.59
52 Week Low	$0.8101
Revenue TTM	$0.0
EBITDA	$-17.9M
Earnings Per Share (EPS)	$-0.98
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-61.17%

How to invest in Enlivex Therapeutics from India?

It is very easy for Indian residents to invest directly in Enlivex Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Enlivex Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Enlivex Therapeutics or ENLV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Enlivex Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Enlivex Therapeutics shares which would translate to 0.693 fractional shares of Enlivex Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Enlivex Therapeutics, in just a few clicks!

Returns in Enlivex Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Enlivex Therapeutics investment value today

Current value as on today

₹46,167

Returns

₹53,833

(-53.83%)

Returns from Enlivex Therapeutics Stock

₹56,071 (-56.07%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Enlivex Therapeutics

62%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Enlivex Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 62% more investors are searching Enlivex Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Enlivex Therapeutics

Armistice Capital, LLC
9.73%
Morgan Stanley - Brokerage Accounts
1.12%
Renaissance Technologies Corp
0.34%
Sigma Investment Counselors Inc
0.14%
XTX Topco Ltd
0.10%
Goldman Sachs Group Inc
0.06%

Analyst Recommendation on Enlivex Therapeutics

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Enlivex Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Enlivex Therapeutics

What analysts predicted

Upside of 672.36%

Current:

$1.23

Target:

$9.50

Insights on Enlivex Therapeutics

Price Movement
In the last 1 month, ENLV stock has moved up by 15.0%
ENLV vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 79.0%
ENLV vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 105.4%

Enlivex Therapeutics Technicals Summary

Sell

Neutral

Buy

Enlivex Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Enlivex Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Enlivex Therapeutics Ltd	14.95%	-18.0%	-56.07%	-80.48%	-85.58%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Enlivex Therapeutics Ltd	NA	NA	NA	-0.65	-0.61	-0.27	NA	1.62
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Enlivex Therapeutics Ltd	Buy	$27.0M	-85.58%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Enlivex Therapeutics

enlivex therapeutics ltd., a clinical stage immunotherapy company, engages in developing allogeneic drugs for immune system rebalancing. its product candidate is allocetra, an immunotherapy candidate, which is in phase iib clinical trial in patients with severe sepsis; that is in investigator-initiated phase ii clinical trial for the treatment of covid-19 patients in severe and critical conditions; and which is in phase iia clinical trial for the prevention of graft versus host disease in allogeneic hematopoietic stem cell transplants (hsct) patients. the company is also developing allocetra for the prevention of complications associated with bone marrow transplantations and/or hsct, and acute multiple organ failure. it also intends to develop its cell-based therapy to be combined with treatments of solid tumors via immune checkpoint rebalancing to enhance the efficacy of various anti-cancer therapies, including chimeric antigen receptor t-cell therapy and therapies targeting t-cell re

Organization	Enlivex Therapeutics
Employees	0
CEO	Mr. Shai Novik M.B.A.
Industry	Biotechnology

Management People of Enlivex Therapeutics

Name	Title
Mr. Shai Novik M.B.A.	Executive Chairman
Dr. Oren Hershkovitz Ph.D.	Chief Executive Officer
Ms. Shachar Shlosberger CPA	Chief Financial Officer
Mr. Veronique Amor-Baroukh	Senior Director of Operations
Ms. Sigal Arad	Director of HR

Important FAQs about investing in Enlivex Therapeutics from India :

What is Enlivex Therapeutics share price today?

Enlivex Therapeutics share price today stands at $1.23, Open: $1.23 ; Previous Close: $1.24 ; High: $1.26 ; Low: $1.22 ; 52 Week High: $4.59 ; 52 Week Low: $0.81. The stock opens at $1.23, after a previous close of $1.24. The stock reached a daily high of $1.26 and a low of $1.22, with a 52-week high of $4.59 and a 52-week low of $0.81.

Can Indians buy Enlivex Therapeutics shares?

Yes, Indians can invest in the Enlivex Therapeutics (ENLV) from India.

With INDmoney, you can buy Enlivex Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Enlivex Therapeutics at zero transaction cost.

How can I buy Enlivex Therapeutics shares from India?

It is very easy to buy Enlivex Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Enlivex Therapeutics be purchased?

Yes, you can buy fractional shares of Enlivex Therapeutics with INDmoney app.

What are the documents required to start investing in Enlivex Therapeutics stocks?

To start investing in Enlivex Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.